Dharambir K Sangera
Dr. Dharambir Sanghera is a Professor of Pediatrics, an Adjunct Professor of Pharmaceutical Sciences, and Director of the Genetic Epidemiology Laboratory at the University of Oklahoma Health Sciences Center (OUHSC). Dr. Sanghera did her Masters degree in Genetics from Punjab Agricultural University, Ludhiana, and Ph.D. in Human Genetics/Genetic Toxicology from Guru Nanak Dev University, Amritsar in 1992. Dr. Sanghera’s research specializes in molecular and genetic epidemiological aspects of complex diseases, with special focus on Type 2 Diabetes, Obesity, Coronary Artery Disease, Stroke, and Dyslipidemia. She is an expert in molecular and quantitative genetics with experience of over 20 years for applying these approaches in studying complex diseases using family- and population-based clinical cohorts. She is PI of the Sikh Diabetes Study (SDS)/Asian Indian Diabetic Heart Study (AIDHS) and has been principal investigator and co-investigator on K01, R01, R21, R218 (NIDDK, NHLBI, NHGRI, and FIC) grants and contracts funded though NIH and Foundation grants on health disparity research. She is also the PI of Metabolome in Ischemic Stroke Study (MISS) sponsored by Presbyterian Health Foundation to perform miRNA-metabolome studies on Stroke in Oklahoma natives. Currently, Dr. Sanghera is PI of the INDIGENIUS consortium with Dr. Duggirala (PI), which is jointly funded by NIDDK and Indian Council of Medical Research (ICMR). She serves as a Steering Committee member of the INDIGENIUS and Chairs Publication Committee of this consortium. Her group has effectively led three international consortia studies extending our research activities and collaborations beyond the US, to India, Pakistan, UK, Japan, and Singapore. These collaborations have led to publications in high impact journals.